文献速递神经与头颈病理细胞病理与分子病理

脑动静脉畸形的KRAS激活突变:频率与临床病理相关性

Activating KRAS mutations in arteriovenous malformations of the brain: frequency and clinicopathologic correlation.
PubMed 文献 · Hum Pathol · 2019-04-24

该研究回顾2014-2017年神经病理数据库中切除的脑或硬脑膜动静脉畸形(AVM)21例,检测KRAS突变并分析其与临床病理特征的关系。结果显示6/21例(28.5%)存在KRAS突变,以p.G12V最常见,并首次报道脑AVM中KRAS p.G12C突变;突变组与非突变组在年龄、大小及组织学上无显著差异。

要点

  • 脑AVM中KRAS突变检出率为28.5%(6/21),以p.G12V最常见。
  • 首次报道脑AVM中KRAS p.G12C突变。
  • KRAS突变型与野生型在年龄、大小及组织学上无显著差异。

核心结论

  • KRAS突变发生于近三分之一的脑AVM,p.G12V为最常见突变类型,并首次报道p.G12C突变。
  • KRAS突变组平均年龄低于非突变组、平均体积大于非突变组,但差异无统计学意义。

研究设计与样本

  • 回顾性研究,检索2014-2017年神经病理数据库中切除的脑或硬脑膜AVM病例。
  • 共检测21例AVM(12例女性,9例男性;平均年龄32岁)。

主要发现

  • KRAS突变见于6/21例(28.5%),其中5例为p.G12V、1例为p.G12C。
  • KRAS突变组(4女2男)平均年龄28岁,非突变组平均年龄34岁(P = .54)。
  • KRAS突变组平均AVM大小3.9 cm,非突变组3.1 cm(P = .52)。
  • KRAS突变型与非突变型病例之间无组织学差异。

临床怎么用

  • 脑AVM中KRAS突变较常见,提示部分AVM可能具有分子遗传学驱动因素。
  • KRAS突变状态与年龄、大小及组织学特征无显著关联,暂不能用于临床分层。

局限性

  • 样本量小(21例),统计效能有限。
  • 为单中心回顾性数据库研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Arteriovenous malformations (AVM) of the brain are considered congenital. Most AVMs are presumably sporadic; however, rare familial cases occur and they may be observed in certain genetic disorders. We sought to determine the frequency of KRAS mutations and their association with clinicopathologic characteristics. We searched our neuropathology database from 2014-2017 for resected AVMs of the brain or dura mater. Twenty-one AVMs were tested (12 females, 9 males; average age: 32 years). KRAS mutations were found in 6/21 cases (28.5%). Five mutations were p.G12 V, and one p.G12C. The KRAS-mutant group contained 4 females and 2 males, with an average age of 28 years, compared to 34 years in the non-mutant group (P = .54). The average AVM size in the KRAS-mutant group was 3.9 cm, compared to 3.1 cm in the non-mutant group (P = .52). There were no histologic differences between KRAS-mutant and non-mutant cases. In summary, KRAS mutations occur in almost one-third of brain AVMs. KRAS p.G12 V was the most common mutation identified. We also demonstrate the first reported instance of a KRAS p.G12C mutation in a brain AVM. The mean age of patients with KRAS-mutant AVMs was lower than the non-mutant group, and the mean size larger. Histologic characteristics were equally distributed between KRAS-mutant and non-mutant groups.

来源:Hum Pathol,查看原文。版权归原作者所有。

引用

  1. Priemer DS, Vortmeyer AO, Zhang S, et al. Activating KRAS mutations in arteriovenous malformations of the brain: frequency and clinicopathologic correlation. Hum Pathol. 2019. PMID: 31026472. doi:10.1016/j.humpath.2019.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。